Galectin Therapeutics Inc.GALTNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank73
3Y CAGR-8.7%
5Y CAGR+4.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-8.7%/yr
vs +29.6%/yr prior
5Y CAGR
+4.5%/yr
Recent deceleration
Acceleration
-38.3pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $29.13M | -31.3% |
| 2024 | $42.40M | +11.5% |
| 2023 | $38.04M | -0.7% |
| 2022 | $38.32M | +27.1% |
| 2021 | $30.14M | +28.8% |
| 2020 | $23.41M | +74.6% |
| 2019 | $13.40M | -1.5% |
| 2018 | $13.60M | -16.3% |
| 2017 | $16.25M | -24.4% |
| 2016 | $21.48M | - |